Green Cross (005250) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.074x

Based on the latest financial reports, Green Cross (005250) has a cash flow conversion efficiency ratio of 0.074x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩139.95 Billion ≈ $94.84 Million USD) by net assets (₩1.89 Trillion ≈ $1.28 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Green Cross (005250) total market value for the company's overall valuation and market capitalisation.

Green Cross - Cash Flow Conversion Efficiency Trend (2000–2024)

This chart illustrates how Green Cross's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Green Cross Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Green Cross ranked by their cash flow conversion efficiency. Explore 005250 cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Orbit Technologies Ltd
TA:ORBI
-0.056x
NICE Holdings Co. Ltd
KO:034310
0.070x
Shenzhen Friendcom Technology Development Co Ltd
SHE:300514
0.077x
XAI Octagon Floating Rate & Alternative Income Term Trust
NYSE:XFLT
0.040x
Multilaser Industrial SA
SA:MLAS3
0.021x
INTERGRATED DIA.H DL 025
F:8I8
0.096x
MKH Bhd
KLSE:6114
0.032x
Mount Gibson Iron Ltd
AU:MGX
-0.028x

Annual Cash Flow Conversion Efficiency for Green Cross (2000–2024)

The table below shows the annual cash flow conversion efficiency of Green Cross from 2000 to 2024. View today's stock price for Green Cross for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩1.85 Trillion
≈ $1.26 Billion
₩-89.95 Billion
≈ $-60.96 Million
-0.049x -130.42%
2023-12-31 ₩1.88 Trillion
≈ $1.28 Billion
₩-39.65 Billion
≈ $-26.87 Million
-0.021x -142.67%
2022-12-31 ₩1.97 Trillion
≈ $1.33 Billion
₩97.16 Billion
≈ $65.84 Million
0.049x -9.05%
2021-12-31 ₩1.91 Trillion
≈ $1.29 Billion
₩103.77 Billion
≈ $70.32 Million
0.054x +154.07%
2020-12-31 ₩1.67 Trillion
≈ $1.13 Billion
₩35.77 Billion
≈ $24.24 Million
0.021x +320.95%
2019-12-31 ₩1.51 Trillion
≈ $1.02 Billion
₩7.65 Billion
≈ $5.18 Million
0.005x -80.40%
2018-12-31 ₩1.45 Trillion
≈ $984.76 Million
₩37.64 Billion
≈ $25.51 Million
0.026x -74.19%
2017-12-31 ₩1.44 Trillion
≈ $975.64 Million
₩144.48 Billion
≈ $97.91 Million
0.100x +17256.99%
2016-12-31 ₩1.38 Trillion
≈ $933.18 Million
₩-805.47 Million
≈ $-545.86K
-0.001x -110.87%
2015-12-31 ₩1.31 Trillion
≈ $885.99 Million
₩7.04 Billion
≈ $4.77 Million
0.005x -88.35%
2014-12-31 ₩1.18 Trillion
≈ $800.39 Million
₩54.54 Billion
≈ $36.96 Million
0.046x +189.06%
2013-12-31 ₩1.10 Trillion
≈ $745.23 Million
₩17.57 Billion
≈ $11.91 Million
0.016x -57.76%
2012-12-31 ₩972.83 Billion
≈ $659.27 Million
₩36.80 Billion
≈ $24.94 Million
0.038x -70.84%
2011-12-31 ₩895.76 Billion
≈ $607.04 Million
₩116.18 Billion
≈ $78.73 Million
0.130x -69.37%
2010-12-31 ₩839.83 Billion
≈ $569.14 Million
₩355.62 Billion
≈ $241.00 Million
0.423x -54.13%
2009-12-31 ₩522.78 Billion
≈ $354.28 Million
₩482.60 Billion
≈ $327.05 Million
0.923x +93.20%
2008-12-31 ₩350.47 Billion
≈ $237.51 Million
₩167.47 Billion
≈ $113.49 Million
0.478x -36.16%
2007-12-31 ₩351.08 Billion
≈ $237.92 Million
₩262.77 Billion
≈ $178.07 Million
0.748x +59.53%
2006-12-31 ₩221.73 Billion
≈ $150.26 Million
₩104.03 Billion
≈ $70.50 Million
0.469x +78.48%
2005-12-31 ₩236.96 Billion
≈ $160.59 Million
₩62.29 Billion
≈ $42.22 Million
0.263x -69.80%
2003-12-31 ₩210.22 Billion
≈ $142.46 Million
₩182.96 Billion
≈ $123.99 Million
0.870x +648.32%
2001-12-31 ₩273.93 Billion
≈ $185.64 Million
₩31.86 Billion
≈ $21.59 Million
0.116x -39.13%
2000-12-31 ₩282.15 Billion
≈ $191.21 Million
₩53.91 Billion
≈ $36.53 Million
0.191x --

About Green Cross

KO:005250 Korea Biotechnology
Market Cap
$288.37 Million
₩425.53 Billion KRW
Market Cap Rank
#15093 Global
#493 in Korea
Share Price
₩9470.00
Change (1 day)
-1.87%
52-Week Range
₩9040.00 - ₩17170.00
All Time High
₩51630.05
About

Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pert… Read more